(Updated - October 2, 2026 6:55 AM EDT)

Wedbush analyst Robert Driscoll downgraded Foghorn Therapeutics (NASDAQ: FHTX) from Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE